References
- Ibrahim CP. Haemostatic derangements and lupus anticoagulant in polytransfused patients of beta-thalassaemia major. Asian J Paed Pract 1999;3(2).
- Hilgartner MW, Erlandson ME, Smith CH. The coagulation mechanism in patients with thalassaemia major. J Pediatr 1981;99:700–703.
- Eldor A. Hemorrhagic tendency in beta-thalassaemia major. Isr J Med Sci 1978;14:1132–1134.
- Rai R, Pati H, Arya LS, Saraya AK. Platelet aggregation in homozygous beta thalassaemia. Ind J Med Res 1987;86: 61–64.
- Logothetis J, Constantoulakis M, Econ omiclou J, et al Thalassaemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 1972;22:294–304.
- Pignatti BC, Carnelli V, Caruso V, Dore E, De Mattia D, Di Palma A. Thromboembolic events in beta thalassaemia major—An Italian multicenter study. Acta Haematol 19981999;:76–79.
- Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 2000;111:467–473.
- Sinniah D, Vigenendra V, Ahmad K. Neurological complications of thalassemia major. Arch Dis Child 1977;52: 977–979.
- Michaeli J, Mittelman M, Gisaru D, Rachmilewitz EA. Thromboembolic complications in beta thalassaemia major. Acta Haematol 1992;87:71–74.
- Eldor A, Durst R, Hy-Am E, et al. A chronic hypercoagulable state in patients with beta-thalassemia major is already present in childhood. Br J Haematol 1999;107:739–746.
- Sonakul D, Pacharee P, Lohapand T, Fucharoen S, Wasi P. Pulmonary artery obstruction in thalassemia. Southeast Asian J Trop Med Public Health 1980;11:516–523.
- Friedlander ZG, Rund D. Myocardial infarction in a patient with b-thalassemia major: First report. Am J Hematol 2004;75:52–55.
- Mussumeci S, Leonardo S, Dio RD, Fischer A, Cosia GD. Protein C and Antithrombin III in polytransfused thalassemia patients. Acta haematol 1987;77:30–33.
- Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health 1992;23:65–73.
- Choudhary VP, Kotwal J, Saxena R. Thalassemia screening and control programme. Paediatr Today 1998; 1(3):283–286.
- Lewis SM, Bain BJ, Bates I In: Dacie, Lewis, editors. Practical haematology. 9th ed. London: Churchill Livingstone; 2001.
- Caocci L, Alberti M, Burrai P, Corda R. Sereening coagulation tests and clotting factors in homozygous beta thalassaemia. Acta Haematol 1978;60:358–364.
- Rabiner SF, Rosefeld S. Role of intravascular hemolysis and the reticuloendothelial system in the production of hypercoagulable state. J Lab Clin Med 1963;63:1005–1009.
- Andrew M, Manno M, Kapatkin M. Demonstration of Kallikrein-like protease activity in nonactivated plasma of patients with Cooley’s anemia. Blood 1983;61:232–237.
- Cappellini MD, Coppola R, Bottasso B, Grazlader G, Fargion S, Manucci PM, et al. Hypercoagulability in patients with thalassaemia intermedia. Blood 1995;77:30–33.
- Eldor A, Rachmilewitz EA. The hypercoagulable state in thalassemia. Blood 2002;99:36–43.
- Moratelli S, De Sanctis V, Gemmati D, et al. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab 1998;11: 915–921.